American Airlines Replaces Allergan in S&P 500
American Airlines will be the newest addition to the S&P 500, taking the place of Allergan.
All Work
Chris Lange
What to Expect From Molycorp Earnings
Molycorp is scheduled to report its fourth-quarter financial results Monday after the U.S. markets close.
Why Merrill Lynch Is Now Very Concerned About DuPont
Merrill Lynch does not see much of a chance for an upside in DuPont anymore and downgraded the stock to Underperform.
Why Merrill Lynch Raised Petrobras Argentina and YPF
Argentina has had its share of financial issues, but now we have seen a serious sentiment change for Argentina out of the team at Bank of America Merrill Lynch.
Why Garmin Is Being Downgraded at 52-Week Lows
When shares hit 52-week lows, investors often find themselves forced to take one of two views: the stock has serious problems or it has become a bargain for value investors.
Is the Mobileye Upgrade and Secondary Offering a Goldman Sachs Hatchet Job?
Mobileye has filed for a secondary offering of 14.5 million shares from selling shareholders, but Mobileye will not receive any proceeds from the offering.
As Valeant Ups Salix Buyout, Will Endo Come Back?
Salix Pharmaceuticals and Valeant Pharmaceuticals have announced that they had entered into an agreement on their plan to merge based on a new price for Salix shares.
5 Stocks Investors Must Watch in the Week Ahead
24/7 Wall St. has generated four earnings previews that investors will be watching closely in the week ahead.
5 Highly Unusual Stock Moves of the Past Week
Stocks are still very close to all-time highs, and this bull market is now six years old. It turns out that some stocks made unusual moves last week.
Par Pharma Files for IPO
Par Pharmaceutical Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
FXCM Shows It Is a Survivor
FXCM shares rose sharply after it reported better-than-expected fourth-quarter results Thursday after the markets closed.
Is Civeo Doomed?
Civeo reported better-than-expected fourth-quarter earnings Thursday after the U.S. markets closed.
Does Bill Ackman Feel Humiliated When Herbalife Shares Rise?
Herbalife was under attack yet again on Friday morning by activist investor Bill Ackman on an appearance on CNBC.
More All-Time Highs After Ulta Earnings
Thursday after the markets closed, Ulta Salon, Cosmetics & Fragrance released its fourth-quarter and full-year earnings report.
Strong El Pollo Loco Earnings Could Rekindle Post-IPO Hype
El Pollo Loco Holdings reported better-than-expected fourth-quarter financial results after markets closed on Thursday.
As US Steel Idles Minn. Plant, Will More Plant Idling Follow?
The woes continue to pile on for United States Steel as it announced that it will be idling yet another plant.
Despite Lower Oil Services Targets, Oppenheimer Still Sees Big Upside
Oppenheimer lowered its earnings estimates and price targets on Baker Hughes, Halliburton and Schlumberger based on its U.S. rig count analysis.
Why Intel Fallout Is Muted in Key PC and Semiconductor Giants
Intel disappointed the market after revising its outlook lower for the first quarter of 2015. Reactions were mixed.
The Real Driving Force Behind Great JA Solar Earnings
Thursday before the markets opened, JA Solar strong fourth-quarter earnings and revenue growth.
What to Expect From Dollar General Earnings
Dollar General is scheduled to report its fiscal fourth-quarter financial results Thursday before the markets open.